Danone

Much hope for the coming months

19/02/21 -"The FY20 figures were roughly in line with the expectations. The FY21 outlook seems quite conservative, but positive comments about the potential split of Faber’s roles, divestments or buy-backs were ..."

PDF page sample
Pages
49
Language
English
Published on
19/02/21
Download
You may also be interested by these reports :
16/10/25
Pernod Ricard reported a slightly larger-than-expected organic decline in Q1 25/26, impacted by ongoing destocking and soft consumer demand. However, ...
15/10/25
The change in the target price is due to a change in the analyst covering the stock, complemented by the usage of systematic intrinsic and peer-based ...
15/10/25
Over time, the illicit market has continued to grow, driven by increasing prices of tobacco products and vaping devices. As a result, BAT (REDUCE ; ...
10/10/25
We have revised our estimates after the pre-close call which has highlighted the challenges in the upcoming Q2. Therefore, key adjustments to our ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO